Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter
FDA Approves Revolutionary Eye Drops to Treat Near Vision Loss Without Glasses Vocal Source: Author: | Date: 2025-09-01 14:00:00 Source: Author: | Date: 2025-09-01 14:00:00

(Image Credit: AdobeStock/Brian Jackson) Neuro-ophthalmologist Alfredo Sadun, MD, PhD, has helped uncover surprising results from gene therapy research for Leber hereditary optic neuropathy (LHON), revealing effects far beyond the initially treated eye. LHON is a rare genetic disorder that causes…
TME Pharma’s Strategic Restructuring and Capital Efficiency: A Pathway to Value Realization in Oncology and Ophthalmology AInvest Source: Author: | Date: 2025-09-01 09:30:00 Source: Author: | Date: 2025-09-01 09:30:00

(Image Credit: AdobeStock/Aliaksandr Marko) Barti Software announced a $12 million Series A investment led by Five Elms Capital to scale its go-to-market efforts, grow its team across key functions, and accelerate development of new AI capabilities and workflow automation as Barti expands…
Renowned eye surgeon Dr Sajjad Fazili honoured with ‘excellence award’ at National Ophthalmology Conference Rising Kashmir Source: Author: | Date: 2025-08-30 18:37:00 Source: Author: | Date: 2025-08-30 18:37:00

(Image credit: AdobeStock/Georgii) Jeremiah Tao, MD, FACS, is a clinical professor of ophthalmology and the chief, oculofacial plastic & orbital surgery at the Gavin Herbert Eye Institute at University of California, Irvine. In 2025, be presented a keynote lecture titled “Avoiding…

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts John D. Gelles, OD, FAAO, FIAOMC, FCLSA, FSLS, FBCLA; and John Hovanesian, MD, FACS; discuss the importance of comprehensive…

(Image Credit: AdobeStock/Working Moments) From June 13-14, 2025, Heidelberg Engineering welcomed clinicians to its eponymous hometown of Heidelberg, Germany, and its brand-new campus for the 21st International SPECTRALIS Symposium (ISS)—and Beyond. The 2-day conference was hosted in the newly opened…

The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) to Outlook Therapeutics’ biologics license application (BLA) resubmission for ONS-5010 (bevacizumab-vikg) for the treatment of wet age-related macular degeneration (AMD). The recent CRL included only 1 deficiency, for…

(Image Credit: AdobeStock/rohane) “Modern devices for delivering viscoelastics during viscocanaloplasty have changed greatly over the past few years, resulting in better outcomes with improved ergonomics and user-friendliness for the surgeons who are performing the procedures,” said Edward Yung, MD, of…